Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Neoplasms × Phlebotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 Polycythemia Vera 2 Ovarian Neoplasms 2 Myeloproliferative Disorders 2 Lymphoma 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Thymic aplasia 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Dysautonomias 1 Polycystic Ovary Syndrome 1 Neuroblastoma 1 Neoplasms 1 Mucopolysaccharidosis I 1 Metabolic Syndrome 1 Melanoma 1 Liver Neoplasms 1 Kidney Neoplasms 1 Insulin Resistance 1 Immunologic Deficiency Syndromes 1 Hyperandrogenism 1 Hodgkin Disease 1 Hematologic Neoplasms 1

Interventions

Sorafenib 39 Bevacizumab 14 Oxaliplatin 13 Leucovorin 9 Fluorouracil 9 Doxorubicin 9 Radiofrequency Ablation 8 Hepatectomy 8 Gemcitabine 8 Cisplatin 8 Capecitabine 8 Radiosurgery 7 pembrolizumab 6 Nivolumab 6 Irinotecan 6 Drug Therapy 6 Cryosurgery 6 Carboplatin 6 Talaporfin 5 Mitomycin 5 spartalizumab 4 Melphalan 4 Everolimus 4 Erlotinib Hydrochloride 4 Embolization, Therapeutic 4 Electroporation 4 aldesleukin 3 Surveys and Questionnaires 3 Sunitinib 3 Sirolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548910 2021-03-18

PRICE

Ottawa Hospital Research Institute

Phase NA Completed

62 enrolled 13 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡